Is the priority review voucher program stimulating new drug development for tropical diseases?

• Published in: PLOS Neglected Tropical Diseases
• Main Authors: Kirk W Kerr, Thomas C Henry, Kathleen L Miller
• Format: Article in Journal/Newspaper
• Language: English
• Published: Public Library of Science (PLoS) 2018
• Subjects: Arctic medicine. Tropical medicine; RC955-962; Public aspects of medicine; RA1-1270; Arctic
• Online Access: https://doi.org/10.1371/journal.pntd.0006695; https://doaj.org/article/a482a32b8e504088b478337d2d2f61a5

Congress created the tropical disease priority review voucher program to stimulate new drug development for tropical diseases. An analysis of the pharmaceutical pipeline indicates that the development of drugs for these tropical diseases has increased. However, the effects of the program are not uniform across all diseases, as malaria and tuberculosis have seen significant new drug development, while other diseases have not.